Four medical centres complete trials on Spectrum Dynamics SPECT CT
Spectrum Dynamics Medical verified its digital SPECT CT scanner across four global healthcare institutions validating diagnostic imaging across the 40 to 400 keV range
MORGES, Switzerland - Spectrum Dynamics Medical announced on October 16, 2026, that four major medical centers have completed trials on their enhanced VERITON-CT 400 Series scanner. The new system, dubbed VERITON-CT 400 All-Energy (VERITON-CT 400 AE), showcases improved high-energy theranostics imaging without sacrificing diagnostic accuracy. The system enhancement, introduced in July 2026, will now bear this new name.
Clinical testing was conducted at Florida Theranostics, Schneider Children's Medical Center of Israel, Huntsman Cancer Institute, and CHRU de Nancy. Each institution utilized a different set of isotopes including technetium-99m, iodine-123, lutetium-177, iodine-131, and actinium-225. The trials demonstrated high-quality imaging for general nuclear medicine, diagnostic, and therapeutic procedures across various isotopes.
Spectrum Dynamics Medical CEO Tomer Gabay stated that the VERITON-CT 400 All-Energy is now the centerpiece of their portfolio, exemplifying the future direction of SPECT/CT technology. Dr. Yulim Zingerman, Chief Technology Officer, highlighted the system's digital CZT detection, 360-degree geometry, single-collimator design, and advanced shielding as key engineering components that enable comprehensive imaging across a wide range of studies.
Clinicians at the participating sites reported significant improvements in image clarity, quantitation, and resolution, while maintaining the simplicity of the single-collimator design. Dr. Ashok Muthu Krishnan of Florida Theranostics noted improvements in anatomical clarity and resolution during high-dose post-therapy I-131 scans.
Dr. Zvi Bar-Sever of Schneider Children's Medical Center of Israel praised the platform's ability to perform a broad range of studies on a single digital SPECT/CT system. Dr. Jeff Yap of Huntsman Cancer Institute expressed confidence in the system's potential for post-therapy imaging of actinium-225.
The VERITON-CT 400 All-Energy is a 360-degree digital CZT SPECT/CT platform designed for theranostics, nuclear cardiology, and general nuclear medicine. It supports imaging across low, medium, and high-energy isotopes using a single collimator design. The system is available for order now as a new system or upgrade for existing VERITON-CT 400 installations.
Written by urgent.news from Vietnam Investment Review's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
